In conclusion, our results underline the protective role of RIPK1 in dysimmune hepatitis and the risks of potential defects in the RIPK1 scaffolding function that would sensitize hepatocyte to the death, risking to worsen hepatitis and even to the increase of HCC onset. This evidence concerns the gene RIPK1 and hepatocellular carcinoma.